New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global ...
SUNNYVALE, Calif., March 21, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress SARS-CoV-2, ...
SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...
A new diagnostic test for the novel coronavirus will return results in just 45 minutes, four times faster than existing machines. But the test, emergency use of which was cleared by the Food and Drug ...
SUNNYVALE, Calif., May 29, 2019 /PRNewswire/ -- Cepheid announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for testing throat and rectal specimens with its ...
LONDON (Reuters) - The World Health Organization (WHO) gave its backing on Wednesday to a new molecular test for tuberculosis made by Cepheid which can rapidly diagnose TB, one of the world's biggest ...
Cepheid has supported TB testing worldwide for over 15 years. Xpert MTB/RIF, released in 2009 in collaboration with the Foundation for Innovative New Diagnostics (FIND), was a first-of-its-kind ...
For much of last year, the coronavirus crept, undetected, across eastern Democratic Republic of Congo. Test samples had to be sent more than 1,500 kilometres from remote hospitals to the capital ...
Managing One of the Largest Enterovirus Testing Populations, Children's Medical Center Dallas Among Leading Institutions to Quickly Adopt Cepheid's SUNNYVALE, Calif ...
Add Yahoo as a preferred source to see more of our stories on Google. By Natalie Grover (Reuters) - Danaher Corp said on Tuesday it would buy medical diagnostics company Cepheid in a deal valued at $4 ...
As controversy rises over equal access to Covid-19 medical products, a manufacturer of rapid, point-of care tests is being urged to lower the price of its diagnostic and also increase sales to a World ...
Cepheid's "Xpert Ebola" test will run on the company's GeneXpert system, which is already used to treat drug-resistant forms of tuberculosis.--Courtesy of Cepheid As diagnostics companies race to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results